Seung-Su Kim
Overview
Explore the profile of Seung-Su Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim S, Park I, Kim J, Ka N, Lim G, Park M, et al.
Breast Cancer Res
. 2025 Jan;
27(1):4.
PMID: 39789641
Background: Patients with estrogen receptor (ER)-positive breast cancer (BC) can be treated with endocrine therapy targeting ER, however, metastatic recurrence occurs in 25% of the patients who have initially been...
2.
Ka N, Park M, Kim S, Jeon Y, Hwang S, Kim S, et al.
Cancer Res
. 2023 Jul;
83(18):3045-3058.
PMID: 37395684
Significance: NR1D1 suppresses breast cancer progression and lung metastasis by enhancing antitumor immunity via cGAS-STING pathway activation, which provides potential immunotherapeutic strategies for breast cancer.
3.
Hwang S, Park S, Kim J, Bang S, Kim H, Ka N, et al.
Life Sci
. 2023 Jun;
328:121827.
PMID: 37276910
Aims: In this study, we aimed to investigate previously unrecognized lipid metabolic perturbations in tamoxifen-resistant breast cancer (BC) by conducting comprehensive metabolomics and transcriptomics analysis. We identified the role of...
4.
Lim G, Cho S, Ka N, Lee K, Im S, Kim S, et al.
J Cell Physiol
. 2023 Apr;
238(7):1507-1519.
PMID: 37062941
In tumor microenvironment (TME), macrophages trigger and maintain inflammatory responses that promoting tumor progression. Many cellular proteins are secreted from tumors and modulate their own TME by modulating macrophage phenotypes....
5.
Ka N, Lim G, Kim S, Hwang S, Han J, Lee Y, et al.
Cell Mol Life Sci
. 2022 May;
79(6):306.
PMID: 35593921
Although type I interferons (IFNs) play multifaceted roles during tumorigenesis and cancer treatment, the interplay between type I IFNs and estrogen signaling in breast cancer (BC) microenvironment is not well...
6.
Ka N, Lim G, Hwang S, Kim S, Lee M
Cell Rep
. 2021 Dec;
37(12):110138.
PMID: 34936865
Tumor DNA-damage response (DDR) has an important role in driving type-I interferon (IFN)-mediated host antitumor immunity, but it is not clear how tumor DNA damage is interconnected with the immune...
7.
Kim S, Lee M, Lee M
Breast Cancer Res Treat
. 2020 Jan;
180(1):45-54.
PMID: 31897900
Purpose: Although tamoxifen remains the frontline treatment for ERα-positive breast cancers, resistance to this drug limits its clinical efficacy. Most tamoxifen-resistant patients retain ERα expression which may support growth and...
8.
Won S, Ahmed N, You B, Shim S, Kim S, Ra C
J Anim Sci Technol
. 2018 Feb;
60:3.
PMID: 29479455
Background: Poultry breeding has increased by 306% in Korea, inevitably increasing the production of manure which may contribute to environmental pollution. The nutrients (NP) in the manure are essential for...
9.
Han J, Jung I, Kang W, Kim S, Yeo Y, Park Y
Chron Respir Dis
. 2014 Jun;
11(3):147-152.
PMID: 24906688
The Leicester Cough Questionnaire (LCQ) is a self-administered questionnaire developed in England and validated for reliability. We developed a Korean translation of this questionnaire by applying a sequential forward and...